Differential response to anakinra and adalimumab in a patient with DADA2 syndrome

por Toz, B, Erer, B, Kamali, S, Ocal, L, Gul, A
Publicado 2015

Quality of life changes with canakinumab therapy in adults with colchicine resistant FMF

por Gul, A, Özdogan, H, Kasapcopur, O, Erer, B, Ugurlu, S, Sevgi, S, Turgay, S
Publicado 2015

PW01-015 – Canakinumab in adults with colchicin resistant FMF

por Gül, A, Özdoğan, H, Kasapçopur, Ö, Erer, B, Uğurlu, S, Davis, N, Sevgi, S
Publicado 2013

P01-020 – Starting time of inflammatory attacks in patients

por Berktaş, F, Alpay, N, Toz, B, Bakkaloğlu, OK, Erer, B, Gül, A
Publicado 2013

Bone marrow transplantation for thalassemia

por Lucarelli, G., Angelucci, E., Giardini, C., Baronciani, D., Galimberti, M., Polchi, P., Erer, B.
Publicado 1993

Identification of ERAP1 protein allotypes in the Turkish population and evaluation of their contributions to Behçet's disease risk

por Remmers, EF, Takeuchi, M, Ombrello, MJ, Kirino, Y, Erer, B, Tugal-Tutkun, I, Seyahi, E, Ozyazgan, Y, Gul, A, Kastner, DL
Publicado 2015

CECR1 p.Gly47Arg mutations are not increased in frequency in Turkish Behçet's disease patients compared with healthy controls

por Erer, B, Remmers, E, Takeuchi, M, Ustek, D, Tugal-Tutkun, I, Seyahi, E, Ozyazgan, Y, Gul, A, Ombrello, M, Kastner, D
Publicado 2015

Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants

por Gaziev, D, Galimberti, M, Lucarelli, G, Polchi, P, Giardini, C, Angelucci, E, Baronciani, D, Sodani, P, Erer, B, De Biagi, M, Andreani, M, Agostinelli, F, Donati, M, Nesci, S, Talevi, N
Publicado 2000